Immune‐mediated drug‐induced liver injury secondary to Omeprazole: A case report
Abstract Omeprazole is a rare cause of DILI with autoimmune hepatitis features and should be considered when seeing patients with acute liver injury. The causative drug should be promptly identified and discontinued to avoid any permanent liver damage.
Main Authors: | Sara Seife Hassen, Fateen Ata, Ammara Bint I Bilal, Mohamed Salih Ali, Mahir Petkar, Abdelnaser Y. Awad Elzouki, Muhammad Zahid |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-12-01
|
Series: | Clinical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/ccr3.3421 |
Similar Items
-
Electrolyte disturbances in children receiving omeprazole for gastroesophageal reflux disease
by: Fatemeh Famouri, et al.
Published: (2020-01-01) -
Ticagrelor and omeprazole: A desirable combination in post MI patients?
by: Dimitrios Alexopoulos
Published: (2020-09-01) -
Effect of food on the pharmacokinetics of omeprazole, pantoprazole and rabeprazole
by: Dolores Ochoa, et al.
Published: (2020-07-01) -
Omeprazole impairs vascular redox biology and causes xanthine oxidoreductase-mediated endothelial dysfunction
by: Lucas C. Pinheiro, et al.
Published: (2016-10-01) -
Clopidogrel and proton pump inhibitor (PPI) interaction: separate intake and a non-omeprazole PPI the solution?
by: Kenngott S, et al.
Published: (2010-05-01)